Alpha 2.0
Login Register
» Authors » Joachim Misselwitz

Joachim Misselwitz

Explore the profile of Joachim Misselwitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 849
Followers 0
Related Specialties
Nephrology
Pediatrics
General Surgery
Top 10 Co-Authors
Ulrike John
Tomas Seeman
Ludwig Patzer
Monika Bulla
Jan Janda
Gunter Klaus
Christian Plank
Christine Skerka
Jiri Dusek
Markus J Kemper
Published In
Transplantation
Kidney Blood Press Res
Pediatr Nephrol
J Am Soc Nephrol
Pediatr Transplant
Affiliations
Soon will be listed here.
Recent Articles
1.
Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence
van Gool J, de Jong T, Winkler-Seinstra P, Tamminen-Mobius T, Lax H, Hirche H, et al.
Neurourol Urodyn . 2013 Jun; 33(5):482-7. PMID: 23775924
Objective: Functional urinary incontinence causes considerable morbidity in 8.4% of school-age children, mainly girls. To compare oxybutynin, placebo, and bladder training in overactive bladder (OAB), and cognitive treatment and pelvic...
2.
Mutations in CYP24A1 and idiopathic infantile hypercalcemia
Schlingmann K, Kaufmann M, Weber S, Irwin A, Goos C, John U, et al.
N Engl J Med . 2011 Jun; 365(5):410-21. PMID: 21675912
Background: Vitamin D supplementation for the prevention of rickets is one of the oldest and most effective prophylactic measures in medicine, having virtually eradicated rickets in North America. Given the...
3.
Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors
Seeman T, Pohl M, Misselwitz J, John U
Kidney Blood Press Res . 2009 Dec; 32(6):440-4. PMID: 20016211
Background/aims: Dual blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) has higher antiproteinuric effects than single blockade in adults. In children, little is...
4.
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids
Offner G, Toenshoff B, Hocker B, Krauss M, Bulla M, Cochat P, et al.
Transplantation . 2008 Nov; 86(9):1241-8. PMID: 19005406
Background: Basiliximab, a monoclonal CD25 antibody has proofed effective in reducing acute rejection episodes in adults in various immunosuppressive regimens. The effect of basiliximab in the pediatric population is controversial....
5.
Searching biomarker candidates in serum using multidimensional native chromatography. II Method evaluation with Alport syndrome and severe inflammation
Baum A, Pohl M, Kreusch S, Cumme G, Ditze G, Misselwitz J, et al.
J Chromatogr B Analyt Technol Biomed Life Sci . 2008 Oct; 876(1):31-40. PMID: 18952508
Biomarker search using multidimensional native liquid fractionation of serum in microplates was evaluated. From different donors, homologous sample fractions with UV absorbance depending on state of illness were selected, and...
6.
Ambulatory blood pressure, proteinuria and uric acid in children with IgA nephropathy and their correlation with histopathological findings
Seeman T, Pohl M, John U, Dusek J, Vondrak K, Janda J, et al.
Kidney Blood Press Res . 2008 Oct; 31(5):337-42. PMID: 18946224
Background/aims: In adults, nighttime hypertension and hyperuricemia are new risk factors for progression of IgA nephropathy (IgAN). In children, nighttime blood pressure (BP) and serum uric acid have never been...
7.
Estimated one-yr glomerular filtration rate is an excellent predictor of long-term graft survival in pediatric first kidney transplants
Muscheites J, Wigger M, Drueckler E, Klaassen I, John U, Wygoda S, et al.
Pediatr Transplant . 2008 Jun; 13(3):365-70. PMID: 18537896
Acute rejection episodes following pediatric renal transplantation have been progressively reduced by recent immunosuppressive regimens. Nevertheless, grafts continue to fail over time and surrogate parameters for long-term RGS are lacking....
8.
Gram-negative peritonitis in children undergoing long-term peritoneal dialysis
Zurowska A, Feneberg R, Warady B, Zimmering M, Monteverde M, Testa S, et al.
Am J Kidney Dis . 2008 Feb; 51(3):455-62. PMID: 18295061
Background: The proportion of gram-negative causative organisms in peritoneal dialysis-associated peritonitis is increasing. Little published information for this complication exists in children. The objective of this study is to evaluate...
9.
The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome
Martinez-Barricarte R, Pianetti G, Gautard R, Misselwitz J, Strain L, Fremeaux-Bacchi V, et al.
J Am Soc Nephrol . 2008 Feb; 19(3):639-46. PMID: 18235085
Mutations in the gene encoding complement factor H (CFH) that alter the C3b/polyanions-binding site in the C-terminal region impair the capacity of factor H to protect host cells. These mutations...
10.
Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation
Jungraithmayr T, Wiesmayr S, Staskewitz A, Kirste G, Bulla M, Fehrenbach H, et al.
Transplantation . 2007 Apr; 83(7):900-5. PMID: 17460560
Background: Mycophenolate mofetil (MMF) based immunosuppression after renal transplantation has proven to be safe and beneficial for children and adolescents. However, long-term analysis, in particular of pediatric patients, is scarce....